Ellen Wagner, Ph.D

Dr. Wagner received her PhD in chemical engineering from the University of Texas at Austin, where she studied antibody and TCR engineering for infectious disease. After a brief tenure as a postdoc at Achaogen, where she built microfluidic functional assays for antimicrobial antibody discovery, she joined the bourgeoning Technology Development team at GigaGen. Since then, Ellen has applied her expertise in protein engineering, molecular biology, and synthetic biology to invent and implement methods for generating and characterizing recombinant polyclonal antibody therapeutics. She is a co-author on >10 papers and is an inventor on >5 granted or pending patents.